Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS.

× No keyword cloud information.

3 in total

Review 1. The problem of the patient with thyroglobulin elevation but negative iodine scintigraphy: the TENIS syndrome.

Authors: Edward B Silberstein
Journal: Semin Nucl Med Date: 2011-03 Impact factor: 4.446

Review 2. A reevaluation of integrins as regulators of angiogenesis.

Authors: Richard O Hynes
Journal: Nat Med Date: 2002-09 Impact factor: 53.440

3. Usefulness of 68Ga-DOTA-RGD (αvβ3) PET/CT Imaging in Thyroglobulin Elevation With Negative Iodine Scintigraphy.

Authors: Rakhee Vatsa; Jaya Shykla; Bhagwant Rai Mittal; Priya Bhusari; Apurva Sood; Rajender Kumar Basher; Anish Bhattacharya
Journal: Clin Nucl Med Date: 2017-06 Impact factor: 7.794

3 in total

8 in total

1. Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.

Authors: Zohreh Maghsoomi; Zahra Emami; Ramin Malboosbaf; Mojtaba Malek; Mohammad E Khamseh
Journal: BMC Cancer Date: 2021-05-20 Impact factor: 4.430

Review 2. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.

Authors: Circe D van der Heide; Simone U Dalm
Journal: Eur J Nucl Med Mol Imaging Date: 2022-07-05 Impact factor: 9.236

Review 3. A review of advances in the last decade on targeted cancer therapy using ¹⁷⁷Lu: focusing on ¹⁷⁷Lu produced by the direct neutron activation route.

Authors: Rubel Chakravarty; Sudipta Chakraborty
Journal: Am J Nucl Med Mol Imaging Date: 2021-12-15

Review 4. Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms.

Authors: Amir Iravani; Ashwin Singh Parihar; Timothy Akhurst; Rodney J Hicks
Journal: Cancer Imaging Date: 2022-06-03 Impact factor: 5.605

5. Nephrotoxicity after radionuclide therapies.

Authors: Ashwin Singh Parihar; Sejal Chopra; Vikas Prasad
Journal: Transl Oncol Date: 2021-11-27 Impact factor: 4.243

Review 6. Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors.

Authors: Li Li; Xiaoyuan Chen; Jinming Yu; Shuanghu Yuan
Journal: Front Oncol Date: 2022-03-02 Impact factor: 6.244

Review 7. Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead.

Authors: Swayamjeet Satapathy; Chandrasekhar Bal
Journal: Front Endocrinol (Lausanne) Date: 2022-07-12 Impact factor: 6.055

Review 8. Next-Generation Molecular Imaging of Thyroid Cancer.

Authors: Yuchen Jin; Beibei Liu; Muhsin H Younis; Gang Huang; Jianjun Liu; Weibo Cai; Weijun Wei
Journal: Cancers (Basel) Date: 2021-06-25 Impact factor: 6.639